An Efficacy and Safety Study With Licroca Depot, a Controlled Release Product, Injected Into the Prostate

NCT00913263 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: 2-hydroxyflutamide (2-HOF) [Liproca Depot]
DRUG: 2-Hydroxyflutamide

Sponsor

Lidds AB